Errani C - Search Results

1

Benign albeit glycolytic: MCT4 expression and lactate release in giant cell tumour of bone.

Avnet S, Lemma S, Errani C, Falzetti L, Panza E, Columbaro M, Nanni C, Baldini N. Avnet S, et al. Among authors: errani c. Bone. 2020 May;134:115302. doi: 10.1016/j.bone.2020.115302. Epub 2020 Feb 26. Bone. 2020. PMID: 32112988

2

68Ga-citrate PET/CT for evaluating patients with infections of the bone: preliminary results.

Nanni C, Errani C, Boriani L, Fantini L, Ambrosini V, Boschi S, Rubello D, Pettinato C, Mercuri M, Gasbarrini A, Fanti S. Nanni C, et al. Among authors: errani c. J Nucl Med. 2010 Dec;51(12):1932-6. doi: 10.2967/jnumed.110.080184. Epub 2010 Nov 15. J Nucl Med. 2010. PMID: 21078801 Free article.

3

Treatment for long bone metastases based on a systematic literature review.

Errani C, Mavrogenis AF, Cevolani L, Spinelli S, Piccioli A, Maccauro G, Baldini N, Donati D. Errani C, et al. Eur J Orthop Surg Traumatol. 2017 Feb;27(2):205-211. doi: 10.1007/s00590-016-1857-9. Epub 2016 Sep 20. Eur J Orthop Surg Traumatol. 2017. PMID: 27650452 Review.

4

Cancer-associated mesenchymal stroma fosters the stemness of osteosarcoma cells in response to intratumoral acidosis via NF-κB activation.

Avnet S, Di Pompo G, Chano T, Errani C, Ibrahim-Hashim A, Gillies RJ, Donati DM, Baldini N. Avnet S, et al. Among authors: errani c. Int J Cancer. 2017 Mar 15;140(6):1331-1345. doi: 10.1002/ijc.30540. Int J Cancer. 2017. PMID: 27888521 Free PMC article.

5

How safe and effective is denosumab for bone giant cell tumour?

Errani C, Tsukamoto S, Mavrogenis AF. Errani C, et al. Int Orthop. 2017 Nov;41(11):2397-2400. doi: 10.1007/s00264-017-3536-9. Epub 2017 Jun 23. Int Orthop. 2017. PMID: 28646421 Review.

6

Intratumoral acidosis fosters cancer-induced bone pain through the activation of the mesenchymal tumor-associated stroma in bone metastasis from breast carcinoma.

Di Pompo G, Lemma S, Canti L, Rucci N, Ponzetti M, Errani C, Donati DM, Russell S, Gillies R, Chano T, Baldini N, Avnet S. Di Pompo G, et al. Among authors: errani c. Oncotarget. 2017 Apr 13;8(33):54478-54496. doi: 10.18632/oncotarget.17091. eCollection 2017 Aug 15. Oncotarget. 2017. PMID: 28903357 Free PMC article.

7

Denosumab May Increase the Risk of Local Recurrence in Patients with Giant-Cell Tumor of Bone Treated with Curettage.

Errani C, Tsukamoto S, Leone G, Righi A, Akahane M, Tanaka Y, Donati DM. Errani C, et al. J Bone Joint Surg Am. 2018 Mar 21;100(6):496-504. doi: 10.2106/JBJS.17.00057. J Bone Joint Surg Am. 2018. PMID: 29557866

8

Denosumab does not decrease the risk of lung metastases from bone giant cell tumour.

Tsukamoto S, Mavrogenis AF, Leone G, Righi A, Akahane M, Tanzi P, Kido A, Honoki K, Tanaka Y, Donati DM, Errani C. Tsukamoto S, et al. Among authors: errani c. Int Orthop. 2019 Feb;43(2):483-489. doi: 10.1007/s00264-018-4085-6. Epub 2018 Aug 11. Int Orthop. 2019. PMID: 30099641

9

Tsukamoto S, Mavrogenis AF, Tanzi P, Leone G, Righi A, Akahane M, Kido A, Honoki K, Tanaka Y, Donati DM, Errani C. Tsukamoto S, et al. Among authors: errani c. J Surg Oncol. 2019 Jun;119(7):864-872. doi: 10.1002/jso.25391. Epub 2019 Feb 7. J Surg Oncol. 2019. PMID: 30734307

10

The role of 18F-FDG PET/CT in soft tissue sarcoma.

Sambri A, Bianchi G, Longhi A, Righi A, Donati DM, Nanni C, Fanti S, Errani C. Sambri A, et al. Among authors: errani c. Nucl Med Commun. 2019 Jun;40(6):626-631. doi: 10.1097/MNM.0000000000001002. Nucl Med Commun. 2019. PMID: 30908341

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters